| [1] |
Nonn O, Debnath O, Valdes DS, et al. Senescent syncytiotrophoblast secretion during early onset preeclampsia[J]. Hypertension，2025，82(5)：787-799.
|
| [2] |
Kwak S, Park CS, Park Y, et al. Hypertensive disorders of pregnancy subtypes and long-term cardiovascular risk[J]. JAMA Intern Med，2027，186(4)：469-478.
|
| [3] |
Yang F, Janszky I, Gissler M, et al. Association of maternal preeclampsia with offspring risks of ischemic heart disease and stroke in Nordic countries[J]. JAMA Netw Open，2022，5(11)：e2242064.
|
| [4] |
Giesen EM, Verlohren S, Blois SM. Multi-omic insights of preeclampsia and cardiovascular health outcomes[J]. Commun Med (Lond)，2025，5(1)：446.
|
| [5] |
陈钰，李力. 免疫代谢调控在子痫前期发病中的最新研究进展[J]. 现代妇产科进展，2024，33(10)：787-790.
|
| [6] |
陈钰，李京阳，李力，等. 内分泌因素调控子痫前期发病的研究进展[J]. 中华妇产科杂志，2025，60(7)：571-573.
|
| [7] |
Deer E, Herrock O, Campbell N, et al. The role of immune cells and mediators in preeclampsia[J]. Nat Rev Nephrol，2023，19(4)：257-270.
|
| [8] |
Burwick RM, Rodriguez MH. Angiogenic biomarkers in preeclampsia[J]. Obstet Gynecol，2024，143(4)：515-523.
|
| [9] |
Platero J, Garcia-Manau P, Costa N, et al. Abnormal soluble fms-like tyrosine kinase to placental growth factor ratio during pregnancy and subjective memory impairment 3 to 6 years postpartum[J]. Am J Obstet Gynecol，2026，235(1)：175-183.
|
| [10] |
Silasi M, Azzi M, Potchileev S, et al. Placental biomarker testing for evaluation of suspected preeclampsia[J]. Clin Chem，2025，71(5)：548-558.
|
| [11] |
Anwer TZ, Cantonwine DE, Seely EW, et al. Obstetric history versus biomarkers: hypertension risk up to 15 years postpartum[J]. Hypertension，2026，83(7)：e25552.
|
| [12] |
Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine Special Statement: prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement[J]. Am J Obstet Gynecol，2023，229(2)：B2-9.
|
| [13] |
Martini C, Saeed Z, Simeone P, et al. Preeclampsia: insights into pathophysiological mechanisms and preventive strategies[J]. Am J Prev Cardiol，2025，23：101054.
|
| [14] |
Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia[J]. Lancet，2021，398(10297)：341-354.
|
| [15] |
Wilson S, Carson E, Fu L, et al. The accuracy of the soluble fms-like tyrosine kinase 1/placental growth factor ratio assay in predicting time to delivery in patients with suspected preeclampsia[J]. Am J Obstet Gynecol，2026，235(2)：409-420.
|
| [16] |
Magee LA, Wright D, Syngelaki A, et al. Preeclampsia prevention by timed birth at term[J]. Hypertension，2023，80(5)：969-978.
|
| [17] |
Attanasio LB, Goff S, Hardeman R, et al. Severe maternal morbidity by race and ethnicity and birth mode among individuals with a prior cesarean birth[J]. JAMA Netw Open，2025，8(6)：e2513578.
|
| [18] |
Xiao F, Xu Q, Yang ZS, et al. The effect of intravenous ondansetron on maternal spinal-induced hypotension in preeclamptic patients undergoing caesarean delivery: a randomised, controlled clinical trial[J]. Eur J Anaesthesiol，2026. Online ahead of print.
|
| [19] |
Park SK, Kim H, Kim Y, et al. Effect of epidural anesthesia on the optic nerve sheath diameter in patients with pre-eclampsia: a prospective observational study[J]. Reg Anesth Pain Med，2025，50(10)：828-834.
|
| [20] |
Dennis AT, Xin A, Farber MK. Perioperative management of patients with preeclampsia: a comprehensive review[J]. Anesthesiology，2025，142(2)：378-402.
|
| [21] |
Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia[J]. Am J Obstet Gynecol，2022，226(2S)：S988-1005.
|
| [22] |
Masini G, Foo LF, Tay J, et al. Preeclampsia has two phenotypes which require different treatment strategies[J]. Am J Obstet Gynecol，2022，226(2S)：S1006-1018.
|
| [23] |
郑晓芳，魏宋荃，黄真轩，等. 子痫前期合并胎儿生长受限的妊娠结局及胎盘病理改变的研究[J/OL].中华产科急救电子杂志，2023，12(2)：85-92.
|
| [24] |
周燕媚，孙雯，林琳，等. 子痫前期并发心力衰竭的诊治和评估[J/OL]. 中华产科急救电子杂志，2022，11(4)：228-233.
|
| [25] |
Guglielminotti J, Landau R, Daw J, et al. Use of labor neuraxial analgesia for vaginal delivery and severe maternal morbidity[J]. JAMA Netw Open，2022，5(2)：e220137.
|
| [26] |
Penfield CA, Oakes MC, Caballero D, et al. A randomized trial of postpartum ibuprofen in severe hypertensive disorders of pregnancy[J]. Am J Obstet Gynecol，2025，233(3)：199.e1-199.e8.
|